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Peripheral T-cell lymphoma presenting as
testicular mass; a diagnostic challenge
Saroona Haroon* and Arsalan Ahmed
Abstract
Background: T-cell lymphomas involve the testis infrequently, which deserve special attention because of the poor
prognosis and the need to make an appropriate diagnosis, which could lead to a better therapeutic strategy.
Case presentation: A 40-year-old man presented with right testicular swelling for past three months. The swelling
was painless, hard and rubbery. Testicular ultrasound showed diffuse increase in size of the testicle, with alteration
in its echogenicity. The patient underwent orchidectomy, and based on histopathological and
immunohistochemical tests, a peripheral T-cell lymphoma, not otherwise specified was diagnosed.
Conclusion: Testicular peripheral T-cell lymphomas are rare and aggressive cancers, with clinical differentials of
seminoma and non-neoplastic conditions.
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Background
Testicular lymphomas comprise 5% of testicular malig-
nancies and these account for about 1% of all lymphomas.
Most of these present at the age of over 60 years, with
mean age 56 years. The testicular lymphomas are usually
disseminated at the time of presentation [1,2]. The pheno-
type of the lymphomas is almost always B-cell type with
most of the tumors being the diffuse large B-cell subtype;
however, rarely, anaplastic lymphoma, Burkitt’s lymph-
oma, or Hodgkin’s lymphoma may involve the testis as the
primary site [1-3]. T-cell lymphoma of the testis is rare
whether as a primary or secondary tumor. Better progno-
sis is predicted if the tumor is a primary, localized to the
testis (5-year survival 60% vs. 17% for disseminated
disease/other stages) and unilateral. Best treatment op-
tions are orchiectomy and chemotherapy, along with
radiation [4].
The gross morphology of a lymphoma appears as white-
tan-pink coloured, and fleshy, resembling a seminoma,
and it often presents with extratesticular involvement
[2,4]. Microscopically splayed apart, but relative sparing of
tubules by lymphoma cells is seen and foci of vascular in-
vasion in are seen in 60% of patients. There is significant
sclerosis in 30% of cases. The non-cohesive tumor cells
have large irregular nuclei, and prominent nucleoli; the
cells show moderate to marked pleomorphism. No
intratubular germ cell neoplasia is seen, which is present
in seminoma, a major differential diagnosis on morph-
ology [2,4].
Case presentation
A 40-year old Asian male patient reported to the general
surgical outpatient department at Mayo Hospital, Lahore
in October 2011 with the history of a rapidly enlarging
painless lump in his right scrotum for the past two
months. There were no comorbid conditions. He was
married with three children; all of them were alive and
healthy. His previous medical and surgical history was
unremarkable.
On physical examination, a non-tender lump measur-
ing 4.0 × 3.5 cm, firm-to-hard in consistency, was
present as a right testicular swelling. It was associated
with slight skin puckering. Examination of the other, that
is, the left testis was unremarkable. There was no gener-
alized lymphadenopathy on general physical examin-
ation. The liver and spleen were of normal size.
Sonographic examination of the scrotum revealed a
well-defined, hypoechoic space-occupying lesion in the
cranial and lateral aspect of the right testis. Findings on
sonographic and computerized tomography (CT) examina-
tions of the abdomen were normal. Differential diagnosis
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for this sonographic appearance was seminoma and orchi-
tis. His erythrocyte sedimentation rate (ESR) was within
normal range and the Montoux test for Mycobacterium
tuberculosis was negative. His complete blood counts at
the time of presentation were within normal limits. On dis-
cussion with the patient, he was informed that benign
pathology such as isolated tuberculous orchitis was a possi-
bility and informed consent was taken.
Testicular biopsy was performed under general
anesthesia and the specimen was sent in formalin to the
Histopathology Laboratory, Aga Khan University Hos-
pital, Karachi. The histopathological examination re-
vealed markedly necrotic tissue with foci of the lesion.
Histologic examination of the specimens revealed a dif-
fuse proliferation of malignant round cells within the
interstitium of the testicular parenchyma. The cells were
present in the form of sheets with scant cytoplasm and
slight variation in size and shape of medium-to-large nu-
clei, which frequently showed irregular foldings and
granular chromatin. Mitotic activity was also observed
with mitoses seen at a rate of 16/10 high power fields.
Intervening scattered vessels were also present. These cells
infiltrated around the seminiferous and epididymal tu-
bules and presented in a discohesive pattern (Figure 1).
Immunohistochemical stains were applied and neo-
plastic cells showed positivity with T-cell markers CD3
and CD 43 (Figures 2 and 3). CD 56 was also positive
(Figure 4). Pan B (CD20), CD 4, CD 8, CD 5 and the epi-
thelial marker cytokeratin were negative. Epstein-Barr
virus (EBV) detection was done through immunohisto-
chemistry by using EBV-latent membrane protein (LMP),
which was also negative. The study was not experimental
and no identifiable material was used in the manuscript,
so this study did not require ethical approval.
Discussion
Although primary testicular lymphoma (PTL) is the
most common form of testicular cancer in men over the
age of 60, and accounts for 7% of all testicular tumors, it
accounts for only 1% of all non-Hodgkin’s Lymphomas
and represents up to 38% of bilateral tumors. It is the
most common testicular tumor in the patient age range
60 to 80 years and has a mean age on presentation of 64
years, but our patient unusually presented at 40 years of
age [1-4].
In primary T-cell lymphomas, most case reports are of
T-cell/Natural Killer (NK) cell lymphoma with very few
cases of peripheral T-cell lymphoma (NOS). Our case
represents one of those few cases of peripheral T-cell
lymphomas previously reported in the literature [4-6].
EBV-associated T-cell/NK cell lymphomas most com-
monly involve the nasal cavities, and these are aggressive
Figure 1 The tumor cells are splaying the seminiferous tubules
apart and present in form of discohesive cells (Hemotoxylin
and eosin, 20×).
Figure 2 Immunohistochemical stain CD-3 positivity in the
tumor cells.
Figure 3 CD-43 immunostain was also positive in the
neoplastic cells.
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extranodal lymphomas. These are rarely encountered at
sites other than the upper aero-digestive tract [6,7].
Clinical presentation is usually of a painless, unilateral
testicular swelling. Symptoms of occasional sharp pain
have been documented, with cases of abdominal pain
with ascites being reported due to large retroperitoneal
lymph nodes. Our patient had also had a painless tes-
ticular mass for the past three months. No pain or asci-
tes was reported at the time of presentation [7,8].
Associated B symptoms (fever, night sweats, weight loss)
usually present only in advanced stages, accounting for
25% to 41% of patients at diagnosis, and these were also
not present in our patient [7-9].
A malignant lymphoma in which the tumor mass is
limited to the testis at the time of clinical onset of the
disease is rare. Since the first report of non-Hodgkin
lymphoma manifesting as a testicular mass, described by
Malassez in 1877, primary testicular lymphoma has
attracted attention because of its rarity and poor prognosis.
Testicular lymphoma is a lethal disease with a median sur-
vival of approximately 12 to 24 months [2,4,8]. Our patient
had no other lymphadenopathy or splenohepatomegaly as
was demonstrated by CT. Until now, 11-month follow up
has been done and the patient is alive. He received chemo-
therapy, the conventional cyclophosphamide, adriamycin,
vincristine, and prednisolone (CHOP) regimen initially.
However, recurrence of the mass developed after 8
months and ipisilateral inguinal lymph node involve-
ment was also present. The patient is now under radio-
therapy treatment [7,8].
Most of patients with testicular large-cell lymphoma
have a poor outcome and the long-term survival curves
show no clear evidence of a substantial proportion of
cured patients. Even for patients with stage I disease and
good-risk International prognostic index (IPI), the
outcome seems worse than that reported for diffuse
large cell lymphoma (DLCL) at other sites [7-9]. There
are reports of a high rate of extranodal recurrence and
the frequent involvement of unusual sites. The duration
of survival after relapse seems to be poor. Failures usu-
ally occur within 1 to 3 years after the initial therapy
[7,9,10]. However, several late relapses of testicular
lymphomas have been observed up to 14 years after
diagnosis, especially in the central nervous system
(CNS) and the contralateral testis, the latter raising the
problem of distinguishing a new primary disease versus
a late recurrence. The possibility of late CNS relapses
has been reported in other studies as well, and is in
marked contrast with the median time to CNS relapse of
less than 1 year in patients with aggressive nodal lymph-
omas, so long-term follow up is mandatory for these pa-
tients [10,11].
This report indicates that testicular T-cell lymphoma
deserves to be distinguished from the other testicular
lymphomas for example, diffuse large B-cell lymphoma
and Hodgkin’s lymphoma, because of the different treat-
ment options. In fact, this lymphoma tends to occur at a
younger age, to disseminate early, to have an aggressive
course, and is strongly associated with EBV [4,10]. Re-
sponse to multi-agent chemotherapy (such as CHOP,
bleomycin, adriamycin, cyclophosphamide, vincristine,
and prednisone (BACOP), or ProMACE-CytaBOM is
often poor, even if complete remission is obtained, re-
lapse may develop soon after. More aggressive treatment
should be sought for this particular malignancy. A com-
mon protocol has still not been developed for refractory
or relapsed peripheral T-cell lymphoma. Some com-
monly used regimens in these cases are ifosfamide,
carboplatin, and etoposide (ICE), dexamethasone, high
dose Ara C, and cisplatin (DHAP) and etoposide, meth-
ylprednisolone, cytarabine, and cisplatin (ESHAP). Also
various clinical trials are underway using histone
deacetylase inhibitors, proteosome inhibitors, nucleoside
analogues, monoclonal antibodies and immunomodula-
tory drugs [10-12].
Conclusions
Testicular peripheral T-cell lymphomas are rare and
highly aggressive cancers, with clinical and histological
differentials of seminoma and non-neoplastic conditions.
Correct diagnosis with immunohistochemical techniques
is mandatory for the proper treatment and further di-
rected management of these tumors.
Consent
Written informed consent was obtained from the patient
for publication of this report and any accompanying
images.
Figure 4 Strong expression of immunohistochemical
stain CD-56.
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